The U.S. Food and Drug Administration approved Ferriprox (deferiprone) to treat patients with iron overload due to blood transfusions in patients with thalassemia, a genetic blood disorder that causes anemia, who had an inadequate response to prior chelation therapy. Patients with thalassemia have excess iron in the body from the frequent blood transfusions (transfusional iron [ Read More ]
Insuraprise, Inc. wishes to remind seniors that Annual Enrollment Period (AEP) has changed this year to October 15th – December 7th with the passage of the Patient Protection and Affordable Care Act of 2010. During the AEP Medicare patients will be able to: Change from a Medicare Advantage Plan back to Original Medicare. Switch from [ Read More ]
Snow shoveling in frigid temps is a risky combination for heart disease patients As Midwesterners brace for seasonal snowfalls, Northwestern Medicine experts of the Bluhm Cardiovascular Institute urge persons with known heart disease to take caution when removing snow. Because shoveling is a physical activity that raises heart rate and blood pressure, Bluhm clinicians recommend [ Read More ]
After a heart attack and the victim stops breathing, a process of irreversible brain damage starts to occur within 3 to 4 minutes. Or does it? While researching cardiac arrest, Jeffrey Dobkin read about a boy drowning in icy waters. Although submerged for over half an hour the boy was rescued, resuscitated, and recovered completely. [ Read More ]
Monthly blood transfusions combined with daily medication to remove the resulting excess iron remains the best approach for reducing the risk of recurrent strokes in young patients with sickle cell anemia, according to a preliminary analysis of a multicenter trial that includes St. Jude Children’s Research Hospital. The study compared the efficacy of two treatments [ Read More ]
Reducing radiation dose is a high priority for medical imaging manufacturers and healthcare facilities. Expanding its dedication to reducing CT radiation dose while maintaining diagnostic confidence, Toshiba America Medical Systems, Inc. is expanding its suite of low dose CT technologies. Toshiba will showcase dose reduction technologies, such as Target CTA and Adaptive Iterative Dose Reduction [ Read More ]